Successful Posaconazole Therapy of Disseminated Alternariosis due to Alternaria infectoria in a Heart Transplant Recipient
Language English Country Netherlands Media print-electronic
Document type Case Reports, Journal Article
PubMed
27866319
DOI
10.1007/s11046-016-0094-4
PII: 10.1007/s11046-016-0094-4
Knihovny.cz E-resources
- Keywords
- Alternariosis, Heart transplantation, Phaeohyphomycosis, Pulmonary infection,
- MeSH
- Alternaria classification drug effects genetics isolation & purification MeSH
- Antifungal Agents therapeutic use MeSH
- Debridement MeSH
- Dermatomycoses diagnosis drug therapy microbiology MeSH
- DNA, Fungal chemistry genetics MeSH
- Histocytochemistry MeSH
- Middle Aged MeSH
- Humans MeSH
- DNA, Ribosomal Spacer chemistry genetics MeSH
- Microscopy MeSH
- Phaeohyphomycosis diagnosis drug therapy microbiology MeSH
- Lung Diseases, Fungal diagnosis drug therapy microbiology MeSH
- Transplant Recipients MeSH
- Sequence Analysis, DNA MeSH
- Heart Transplantation MeSH
- Triazoles therapeutic use MeSH
- Tubulin genetics MeSH
- Treatment Outcome MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Names of Substances
- Antifungal Agents MeSH
- DNA, Fungal MeSH
- DNA, Ribosomal Spacer MeSH
- posaconazole MeSH Browser
- Triazoles MeSH
- Tubulin MeSH
We report a case of phaeohyphomycosis caused by Alternaria infectoria in a 61-year-old heart transplant recipient with multiple skin lesions and pulmonary infiltrates. The infection spread via the haematogenous route from the primary cutaneous lesions into the lungs. The diagnosis was based on the histopathological examination, direct microscopy, skin lesion cultures and detection of Alternaria DNA in the bronchoalveolar lavage fluid using molecular methods. The treatment consisted of a combination of surgical excision and systemic antifungal therapy. Voriconazole was the first agent used but had a weak effect. Posaconazole was subsequently used to achieve a successful response. The isolate was identified as A. infectoria by sequencing of the rDNA ITS region and the partial β-tubulin gene.
See more in PubMed
Med Mycol. 2012 Jul;50(5):518-21 PubMed
Infect Dis Clin North Am. 2013 Jun;27(2):305-16 PubMed
Am J Transplant. 2002 Aug;2(7):678-83 PubMed
Mycologia. 2013 May-Jun;105(3):530-46 PubMed
Stud Mycol. 2015 Sep;82:1-21 PubMed
J Clin Microbiol. 2008 May;46(5):1793-803 PubMed
Clin Drug Investig. 2013 Feb;33 Suppl 1:S33-6 PubMed
J Nephrol. 2006 Sep-Oct;19(5):668-72 PubMed
Transpl Infect Dis. 2010 Jun;12 (3):242-50 PubMed
Haematologica. 2004 Feb;89(2):207-14 PubMed
Actas Dermosifiliogr. 2014 Oct;105(8):e51-4 PubMed
G Ital Dermatol Venereol. 2015 Feb;150(1):73-85 PubMed
Transpl Infect Dis. 2014 Apr;16(2):270-8 PubMed
Diagn Microbiol Infect Dis. 2010 Oct;68(2):177-80 PubMed
Stud Mycol. 2013 Jun 30;75(1):171-212 PubMed
Mol Plant Pathol. 2003 Jul 1;4(4):225-36 PubMed
Clin Microbiol Infect. 2014 Apr;20 Suppl 3:47-75 PubMed
J Clin Microbiol. 2001 May;39(5):1952-5 PubMed
J Antimicrob Chemother. 2009 Jun;63(6):1295-7 PubMed
Eur J Clin Microbiol Infect Dis. 2009 Apr;28(4):377-80 PubMed
Med Mycol. 2014 Aug;52(6):565-76 PubMed
Clin Infect Dis. 2002 Feb 15;34(4):467-76 PubMed
Med Mycol. 2013 Feb;51(2):196-202 PubMed
Rev Iberoam Micol. 2014 Apr-Jun;31(2):149-51 PubMed
Med Mycol. 2011 Jul;49(5):543-7 PubMed
Dermatol Ther. 2014 May-Jun;27(3):140-3 PubMed
Clin Microbiol Rev. 2010 Oct;23(4):884-928 PubMed
Int J Infect Dis. 2010 Sep;14 Suppl 3:e329-32 PubMed
Med Mycol Case Rep. 2015 Jan 29;8:1-4 PubMed
Clin Infect Dis. 2010 Apr 15;50(8):1091-100 PubMed
J Antimicrob Chemother. 2011 Nov;66(11):2585-7 PubMed
Transpl Infect Dis. 2009 Aug;11(4):330-2 PubMed
Clin Infect Dis. 2012 Feb;54 Suppl 1:S23-34 PubMed
Clin Vaccine Immunol. 2009 Mar;16(3):423-6 PubMed
Fungal Genet Biol. 2009 Sep;46(9):642-56 PubMed
Med Mycol. 2015 Jun;53(5):440-6 PubMed
Clin Microbiol Infect. 2008 Aug;14(8):734-46 PubMed